306 related articles for article (PubMed ID: 22263709)
1. Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions.
Friedmann PD; Hoskinson R; Gordon M; Schwartz R; Kinlock T; Knight K; Flynn PM; Welsh WN; Stein LA; Sacks S; O'Connell DJ; Knudsen HK; Shafer MS; Hall E; Frisman LK;
Subst Abus; 2012; 33(1):9-18. PubMed ID: 22263709
[TBL] [Abstract][Full Text] [Related]
2. Court personnel attitudes towards medication-assisted treatment: A state-wide survey.
Andraka-Christou B; Gabriel M; Madeira J; Silverman RD
J Subst Abuse Treat; 2019 Sep; 104():72-82. PubMed ID: 31370988
[TBL] [Abstract][Full Text] [Related]
3. Criminal justice continuum for opioid users at risk of overdose.
Brinkley-Rubinstein L; Zaller N; Martino S; Cloud DH; McCauley E; Heise A; Seal D
Addict Behav; 2018 Nov; 86():104-110. PubMed ID: 29544869
[TBL] [Abstract][Full Text] [Related]
4. Online Medication Assisted Treatment Education for Court Professionals: Need, Opportunities and Challenges.
Matusow H; Rosenblum A; Fong C
Subst Use Misuse; 2021; 56(10):1439-1447. PubMed ID: 34154519
[TBL] [Abstract][Full Text] [Related]
5. The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings.
Chandler RK; Finger MS; Farabee D; Schwartz RP; Condon T; Dunlap LJ; Zarkin GA; McCollister K; McDonald RD; Laska E; Bennett D; Kelly SM; Hillhouse M; Mitchell SG; O'Grady KE; Lee JD
Contemp Clin Trials; 2016 May; 48():166-72. PubMed ID: 27180088
[TBL] [Abstract][Full Text] [Related]
6. Medication assisted treatment in US drug courts: results from a nationwide survey of availability, barriers and attitudes.
Matusow H; Dickman SL; Rich JD; Fong C; Dumont DM; Hardin C; Marlowe D; Rosenblum A
J Subst Abuse Treat; 2013; 44(5):473-80. PubMed ID: 23217610
[TBL] [Abstract][Full Text] [Related]
7. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
[TBL] [Abstract][Full Text] [Related]
8. Medication-assisted treatment research with criminal justice populations: challenges of implementation.
Gordon MS; Kinlock TW; Miller PM
Behav Sci Law; 2011; 29(6):829-45. PubMed ID: 22086665
[TBL] [Abstract][Full Text] [Related]
9. Only One In Twenty Justice-Referred Adults In Specialty Treatment For Opioid Use Receive Methadone Or Buprenorphine.
Krawczyk N; Picher CE; Feder KA; Saloner B
Health Aff (Millwood); 2017 Dec; 36(12):2046-2053. PubMed ID: 29200340
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy for opioid addiction in community corrections.
Schwartz RP; Mitchell MM; O'Grady KE; Kelly SM; Gryczynski J; Mitchell SG; Gordon MS; Jaffe JH
Int Rev Psychiatry; 2018 Oct; 30(5):117-135. PubMed ID: 30522370
[TBL] [Abstract][Full Text] [Related]
11. PROTOCOL: Opioid-specific medication-assisted therapy and its impact on criminal justice and overdose outcomes.
Strange CC; Manchak SM; Hyatt JM; Haberman C; Desai A
Campbell Syst Rev; 2021 Mar; 17(1):e1138. PubMed ID: 37050968
[TBL] [Abstract][Full Text] [Related]
12. Measuring collaboration and integration activities in criminal justice and substance abuse treatment agencies.
Fletcher B; Lehman W; Wexler H; Melnick G; Taxman F; Young D
Drug Alcohol Depend; 2009 Aug; 103 Suppl 1():S54-S64. PubMed ID: 20088023
[TBL] [Abstract][Full Text] [Related]
13. Use of naltrexone in treating opioid use disorder in pregnancy.
Towers CV; Katz E; Weitz B; Visconti K
Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
[TBL] [Abstract][Full Text] [Related]
14. Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians.
Booty MD; Harp K; Batty E; Knudsen HK; Staton M; Oser CB
J Subst Use Addict Treat; 2023 Jun; 149():209051. PubMed ID: 37084815
[TBL] [Abstract][Full Text] [Related]
15. Treatment at the front end of the criminal justice continuum: the association between arrest and admission into specialty substance abuse treatment.
Kubiak SP; Arfken CL; Swartz JA; Koch AL
Subst Abuse Treat Prev Policy; 2006 Jul; 1():20. PubMed ID: 16879743
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of Treatments for Opioid Use Disorder.
Fairley M; Humphreys K; Joyce VR; Bounthavong M; Trafton J; Combs A; Oliva EM; Goldhaber-Fiebert JD; Asch SM; Brandeau ML; Owens DK
JAMA Psychiatry; 2021 Jul; 78(7):767-777. PubMed ID: 33787832
[TBL] [Abstract][Full Text] [Related]
17. Intent to Refer: Exploring Bias Toward Specific Medication-Assisted Treatments by Community Corrections Employees.
Streisel SE
Subst Use Misuse; 2018 Dec; 53(14):2421-2430. PubMed ID: 29958042
[TBL] [Abstract][Full Text] [Related]
18. Financial factors and the implementation of medications for treating opioid use disorders.
Knudsen HK; Roman PM
J Addict Med; 2012 Dec; 6(4):280-6. PubMed ID: 22810057
[TBL] [Abstract][Full Text] [Related]
19. Organizational-level correlates of the provision of detoxification services and medication-based treatments for substance abuse in correctional institutions.
Oser CB; Knudsen HK; Staton-Tindall M; Taxman F; Leukefeld C
Drug Alcohol Depend; 2009 Aug; 103 Suppl 1(Suppl 1):S73-81. PubMed ID: 19108957
[TBL] [Abstract][Full Text] [Related]
20. Improvements in outcomes in methadone patients on probation/parole regardless of counseling early in treatment.
Kelly SM; Oʼgrady KE; Jaffe JH; Gandhi D; Schwartz RP
J Addict Med; 2013; 7(2):133-8. PubMed ID: 23455877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
